Immuron Ltd是一家商业和临床阶段的生物制药公司,专注于多克隆抗体的开发和商业化,以满足未满足的医疗需求。该公司通过两个部门运营:研发(R&D)部门和超免疫产品部门。研发部门专注于在澳大利亚、以色列和美国进行的研发项目。超免疫产品部门在澳大利亚、美国和加拿大从事Travelan和Protectyn产品活动。该公司的旗舰产品包括Travelan和Protectyn。Travelan是一种获得许可的天然保健产品,用于降低旅行者腹泻的风险。Travelan是一种非处方免疫补充剂,可用于降低腹泻风险并减轻轻微胃肠道疾病的症状。Protectyn产品有助于促进消化和健康的胃肠系统健康;支持和维持健康的肝功能,增强免疫防御。
名称 | 标题 | 任期 | 年龄 |
|---|---|---|---|
| Paul Brennan | Independent Non-Executive Chairman | 2023 | 65 |
| Daniel Pollock | Independent Non-Executive Director | 2012 | 66 |
| Dena Lyras | Member of Advisory Board | - | - |
| Ravi Savarirayan | Independent Non-Executive Director | 2017 | 59 |
| Glenn S. Tillotson | Member of Advisory Board | - | - |
| Sahil Khanna | Member of Advisory Board | - | - |
| Paul Feuerstadt | Member of Advisory Board | - | - |
| Teena Chopra | Member of Advisory Board | - | - |
| Jeannette Joughin | Independent Non-Executive Director | 2024 | 62 |